- Home
- SYRE vs EE Comparison
SYRE vs EE Comparison
Compare SYRE & EE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SYRE
- EE
- Stock Information
- Founded
- SYRE 2013
- EE 2003
- Country
- SYRE United States
- EE United States
- Employees
- SYRE N/A
- EE N/A
- Industry
- SYRE Biotechnology: Pharmaceutical Preparations
- EE Oil/Gas Transmission
- Sector
- SYRE Health Care
- EE Utilities
- Exchange
- SYRE Nasdaq
- EE Nasdaq
- Market Cap
- SYRE 1.1B
- EE 902.1M
- IPO Year
- SYRE 2016
- EE 2022
- Fundamental
- Price
- SYRE $23.71
- EE $27.37
- Analyst Decision
- SYRE Strong Buy
- EE Buy
- Analyst Count
- SYRE 5
- EE 7
- Target Price
- SYRE $55.75
- EE $33.00
- AVG Volume (30 Days)
- SYRE 741.8K
- EE 494.0K
- Earning Date
- SYRE 11-04-2025
- EE 11-05-2025
- Dividend Yield
- SYRE N/A
- EE 1.16%
- EPS Growth
- SYRE N/A
- EE 51.11
- EPS
- SYRE N/A
- EE 1.42
- Revenue
- SYRE N/A
- EE $1,185,262,000.00
- Revenue This Year
- SYRE N/A
- EE $27.08
- Revenue Next Year
- SYRE N/A
- EE $29.30
- P/E Ratio
- SYRE N/A
- EE $19.38
- Revenue Growth
- SYRE N/A
- EE 45.09
- 52 Week Low
- SYRE $10.91
- EE $21.29
- 52 Week High
- SYRE $33.47
- EE $32.99
- Technical
- Relative Strength Index (RSI)
- SYRE 60.31
- EE 55.10
- Support Level
- SYRE $21.63
- EE $26.05
- Resistance Level
- SYRE $24.19
- EE $30.37
- Average True Range (ATR)
- SYRE 1.33
- EE 1.05
- MACD
- SYRE -0.26
- EE 0.04
- Stochastic Oscillator
- SYRE 67.01
- EE 44.89
About SYRE Spyre Therapeutics Inc.
Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.
About EE Excelerate Energy Inc.
Excelerate Energy Inc offers LNG solutions, providing integrated services along the LNG value chain. It offers a full range of regasification services, from FSRUs to infrastructure development, to LNG and natural gas supply. Its business spans the globe, with a regional presence in 11 countries and an operational presence in Argentina, Bangladesh, Brazil, Finland, Germany, Pakistan, the United Arab Emirates (UAE), and the United States.